Federated Hermes’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-576,933
Closed -$6.74M 2060
2023
Q4
$6.74M Sell
576,933
-1,600
-0.3% -$15.7K 0.02% 649
2023
Q3
$5.71M Sell
578,533
-171,467
-23% -$2.01M 0.02% 660
2023
Q2
$8.39M Hold
750,000
0.02% 584
2023
Q1
$7.96M Hold
750,000
0.02% 599
2022
Q4
$6.07M Hold
750,000
0.02% 641
2022
Q3
$6.59M Buy
750,000
+385,888
+106% +$4.6M 0.02% 624
2022
Q2
$4.36M Sell
364,112
-325,543
-47% -$4.26M 0.01% 722
2022
Q1
$10.4M Hold
689,655
0.02% 594
2021
Q4
$16.4M Buy
+689,655
New +$16.1M 0.03% 536

Other funds holding EVO

Federated Hermes's EVO Position: Q1 2024 in Review

Federated Hermes sold out of Evotec (EVO) in Q1 2024, closing a stake of 576,933 shares — an estimated $6.74M sold.

Federated Hermes first reported a position in EVO in Q4 2021 and held it in 9 quarters. The position peaked at $16.4M in Q4 2021. 21 funds tracked by Wall St. Rank hold EVO as of Q1 2024.

  • Federated Hermes reported no remaining Evotec position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 576,933 Evotec shares in Q1 2024, an estimated $6.74M.
  • Federated Hermes first reported a position in Evotec in Q4 2021 and held it in 9 quarters.
  • Federated Hermes's Evotec position peaked at $16.4M in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Evotec as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.